Nov 06, 2019 / 10:30AM GMT
Operator
Ladies and gentlemen, good day, and welcome to the Lupin Limited Quarter 2 FY '20 Earnings Conference Call. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to the Lupin management. Thank you, and over to you.
Kamal Kishore Sharma - Lupin Limited - Vice Chairman
Good afternoon, everyone, and welcome to this earnings call for Q2. I would like to start by saying that -- well, let me first introduce my colleagues here in the room who are here to answer your questions. I have Vinita with me; Nilesh; Alok Sonig, who heads the Generic Business in the U.S. as you might have known by now; Rajeev Sibal, head of India business. And we have Sunil Makharia here; (inaudible); Arvind Bothra; and Rajiv Pillai; and of course, Naresh Gupta, the Head of API Plus business.
I just want to start by saying that given the business climate, the competitive dynamics, the regulatory rigor and the risk development in the recent times has given the business of complex generics and specialty and biosimilars. I think the
Half Year 2020 Lupin Ltd Earnings Call Transcript
Nov 06, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers